LIPO – lipella pharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
Lipella Pharmaceuticals First Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.19 loss in 1Q 2023) [Yahoo! Finance]
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise [Yahoo! Finance]
Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise
Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) is now covered by analysts at Maxim Group. They set a "buy" rating and a $2.00 price target on the stock.
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024 [Yahoo! Finance]
Form 4 LIPELLA PHARMACEUTICALS For: May 14 Filed by: Kaufman Jonathan H
Form 10-Q LIPELLA PHARMACEUTICALS For: Mar 31
Form SC 13D/A LIPELLA PHARMACEUTICALS Filed by: Kaufman Jonathan H
Form 8-K LIPELLA PHARMACEUTICALS For: Apr 19
Form 8-K LIPELLA PHARMACEUTICALS For: Apr 12
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.